Explanation
BACKGROUND: Columbus Public Health has been awarded additional grant funds from Gilead Sciences, Inc. for the FOCUS Hep C grant program in the amount of $8,600.00. The purpose of this legislation is to accept and appropriate these additional funds for the FOCUS Hep C grant program for the period ending June 30, 2018.
The FOCUS Hep C grant program will allow Columbus Public Health (CPH) to seek to reduce morbidity and mortality associated with Hepatitis C. Additional Hepatitis C screening will be made available through the Sexual Health and Alcohol and Other Drug programs. Persons who screen positive for Hepatitis C through these programs will be referred to a Linkage to Care Specialist. The client will be assessed for current health insurance status and enrolled in any available programs, including Medicare and Medicaid. The client will be assessed for readiness to be linked to care. Persons ready will be referred to available infectious disease specialists.
This ordinance is submitted as an emergency so as to allow the financial transaction to be posted in the city's accounting system as soon as possible. Up to date financial posting promotes accurate accounting and financial management.
FISCAL IMPACT: The FOCUS Hep C grant program is entirely funded by Gilead Sciences, Inc. This program does not generate revenue nor require a City match.
Title
To authorize and direct the Board of Health to accept supplemental grant funds from Gilead Sciences, Inc. for the FOCUS Hep C grant program in the amount of $8,600.00; to authorize the appropriation of $8,600.00 from the City Private Grants Fund; and to declare an emergency. ($8,600.00)
Body
WHEREAS, $8,600.00 in additional grant funds have been made available through Gilead Sciences, Inc. for the FOCUS Hep C grant program for the period of July 1, 2017 through June 30, 2018; and
WHEREAS, it is necessary to accept and appropriate these funds from Gilead Sciences, Inc. for the continued...
Click here for full text